Comparison of treatment costs of pembrolizumab versus nivolumab in head and neck squamous cell carcinoma.

被引：0
|
作者：
Yeh, Justin
Guddati, Achuta Kumar
机构：
[1] Med Coll Georgia, Augusta, GA 30912 USA
[2] Augusta Univ, Med Coll Georgia, Augusta, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19368
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Immunotherapy with pembrolizumab in surgically resectable head and neck squamous cell carcinoma.
    Uppaluri, Ravindra
    Zolkind, Paul
    Lin, Tianxiang
    Nussenbaum, Brian
    Paniello, Randal
    Rich, Jason
    Jackson, Ryan
    Thorstad, Wade
    Gay, Hiram Alberto
    Daly, Mackenzie
    Kallogjeri, Dorina
    Dunn, Gavin P.
    Wildes, Tanya Marya
    Michel, Loren S.
    Chernock, Rebecca
    Piccirillo, Jay F.
    Griffith, Obi
    Adkins, Douglas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Nivolumab in squamous cell carcinoma of the head and neck
    Specenier, Pol
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (05) : 409 - 420
  • [3] Head and neck squamous cell carcinoma. From pathology to treatment
    Hartmann, S.
    Sayehli, C. M.
    Maurus, K.
    Bhola, N. E.
    Brands, R. C.
    Kuebler, A. C.
    Mueller-Richter, U. D. A.
    [J]. MKG-CHIRURG, 2018, 11 (01): : 30 - 37
  • [4] Pembrolizumab Monotherapy Versus Pembrolizumab Plus Chemotherapy in Patients With Head and Neck Squamous Cell Carcinoma
    Matsuo, Mioko
    Masuda, Muneyuki
    Yamauchi, Moriyasu
    Taura, Masahiko
    Hashimoto, Kazuki
    Kogo, Ryunosuke
    Jiromaru, Rina
    Hongo, Takahiro
    Manako, Tomomi
    Nakagawa, Takashi
    [J]. IN VIVO, 2023, 37 (05): : 2188 - 2196
  • [5] Cost-effectiveness analysis of nivolumab compared to pembrolizumab in the treatment of recurrent or metastatic squamous cell carcinoma of the head and neck
    Yeh, Justin
    Guddati, Achuta Kumar
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (06): : 1821 - 1826
  • [6] Efficacy of Nivolumab and Pembrolizumab in Platinum-sensitive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Yamashita, G. A., I
    Okamoto, I. S. A. K. U.
    Ito, T. A. T. S. U. Y. A.
    Tokashiki, K. U. N. I. H. I. K. O.
    Okada, T. A. K. U. R. O.
    Tsukahara, K. I. Y. O. A. K. I.
    [J]. ANTICANCER RESEARCH, 2023, 43 (08) : 3679 - 3683
  • [7] Pembrolizumab for the treatment of head and neck squamous cell cancer
    Ho, Won Jin
    Mehra, Ranee
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (09) : 879 - 885
  • [8] Bioradiotherapy for head and neck cutaneous squamous cell carcinoma.
    Palmer, Joshua David
    Strasser, Jon
    Hanlon, Alexandra
    Mauer, Elizabeth A.
    Dzeda, Michael
    Hockstein, Neil
    Witt, Robert
    Schneider, Charles
    Raben, Adam
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
    Ferris, R. L.
    Blumenschein, G., Jr.
    Fayette, J.
    Guigay, J.
    Colevas, A. D.
    Licitra, L.
    Harrington, K.
    Kasper, S.
    Vokes, E. E.
    Even, C.
    Worden, F.
    Saba, N. F.
    Iglesias Docampo, L. C.
    Haddad, R.
    Rordorf, T.
    Kiyota, N.
    Tahara, M.
    Monga, M.
    Lynch, M.
    Geese, W. J.
    Kopit, J.
    Shaw, J. W.
    Gillison, M. L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19): : 1856 - 1867
  • [10] Nivolumab for recurrent squamous-cell carcinoma of the head and neck
    [J]. British Dental Journal, 2016, 221 (10) : 632 - 632
12345